Medicus Pharma Ltd. — Director's Dealing 2025

Aug 6, 2025

SEC Form 3/A — Form 3/A

Issuer: Medicus Pharma Ltd. (MDCX)
CIK: 0001997296
Period of Report: 2025-06-30

Reporting Person: Smith Andrew Alasdair (Chief Operating Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares, no par value ("Common Shares")	164	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$2.60	2030-06-30	Common Shares (100000)		Direct

Footnotes

F1: This amendment is being filed to include Common Shares that were inadvertently omitted from the Form 3 filed by the Reporting Person on July 3, 2025.

F2: The board of directors of Medicus Pharma Ltd. (the "Board") approved, during a Board meeting held on July 22, 2025, accelerated vesting of the Reporting Person's options that were otherwise unvested and scheduled to vest annually in five equal installments beginning on June 30, 2026. All these options are now vested.